J 
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co 301130.SZ · CNY
Health Care · Shenzhen · 🇨🇳 China
23.52
-1.55%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥234.8m
FY2014FY2025
Net income
CN¥21.9m
FY2014FY2025
Free cash flow
−CN¥17.4m
FY2014FY2025
Shareholders' equity
CN¥904.3m
FY2014FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥234.8m | CN¥256.4m | CN¥225.5m | CN¥255.5m | CN¥285.7m | CN¥286.3m | CN¥324.9m | CN¥280.2m | CN¥273.5m | CN¥203.6m |
| Gross profit | CN¥179.1m | CN¥195.2m | CN¥180.0m | CN¥208.0m | CN¥238.7m | CN¥242.0m | CN¥277.7m | CN¥240.9m | CN¥238.3m | CN¥174.1m |
| Research and development | CN¥11.3m | CN¥10.2m | CN¥8.7m | CN¥11.7m | CN¥13.3m | CN¥4.4m | CN¥16.6m | CN¥20.6m | CN¥12.0m | — |
| Operating income | CN¥21.0m | CN¥46.3m | CN¥55.7m | CN¥52.1m | CN¥59.7m | CN¥59.2m | CN¥65.4m | CN¥48.5m | CN¥54.2m | CN¥55.0m |
| Net income | CN¥21.9m | CN¥40.3m | CN¥50.5m | CN¥40.7m | CN¥52.0m | CN¥49.7m | CN¥54.6m | CN¥41.4m | CN¥45.6m | CN¥50.9m |
| Diluted earnings per share | 0.29 | 0.53 | 0.63 | 0.50 | 0.86 | 0.82 | 0.71 | 0.54 | 0.60 | 0.67 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥1.06bn | CN¥1.06bn | CN¥1.07bn | CN¥1.02bn | CN¥594.6m | CN¥550.8m | CN¥530.8m | CN¥501.6m | CN¥470.8m | CN¥284.1m |
| Cash and short-term investments | — | CN¥275.6m | CN¥547.5m | CN¥615.9m | CN¥213.6m | CN¥107.7m | CN¥101.4m | CN¥115.9m | CN¥93.4m | CN¥11.7m |
| Total liabilities | CN¥126.8m | CN¥121.4m | CN¥84.3m | CN¥71.7m | CN¥70.5m | CN¥78.6m | CN¥84.1m | CN¥91.5m | CN¥89.9m | CN¥55.1m |
| Debt | — | CN¥10.1m | CN¥197,878 | — | — | — | — | — | — | CN¥3.5m |
| Shareholders' equity | CN¥904.3m | CN¥905.7m | CN¥982.9m | CN¥945.3m | CN¥524.1m | CN¥472.1m | CN¥446.6m | CN¥410.2m | CN¥380.9m | CN¥229.0m |
| Shares outstanding | 77m | 76m | 81m | 81m | 61m | 61m | 77m | 77m | 77m | 77m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥48.6m | CN¥54.2m | CN¥54.4m | CN¥67.2m | CN¥59.0m | CN¥64.5m | CN¥65.9m | CN¥66.1m | CN¥31.3m | — |
| Capital spending | −CN¥66.1m | −CN¥135.0m | −CN¥123.2m | −CN¥54.4m | −CN¥21.2m | −CN¥14.5m | −CN¥13.2m | −CN¥31.1m | −CN¥44.2m | −CN¥50.7m |
| Free cash flow | −CN¥17.4m | −CN¥80.7m | −CN¥68.8m | CN¥12.8m | CN¥37.8m | CN¥50.0m | CN¥52.7m | CN¥35.0m | −CN¥12.9m | — |
| Dividends paid | −CN¥20.3m | −CN¥20.0m | −CN¥12.9m | −CN¥10.5m | — | −CN¥24.2m | −CN¥18.2m | −CN¥12.1m | −CN¥10.8m | −CN¥16.3m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥45.5m | CN¥55.9m | CN¥45.9m | CN¥60.6m | CN¥76.1m | CN¥52.2m | CN¥63.8m | CN¥63.6m |
| Gross profit | CN¥34.4m | CN¥40.8m | CN¥31.7m | CN¥47.4m | CN¥60.1m | CN¥39.9m | CN¥45.3m | CN¥49.7m |
| Operating income | −CN¥2.4m | CN¥9.9m | −CN¥16.3m | CN¥9.2m | CN¥18.1m | CN¥8.9m | CN¥6.7m | CN¥11.1m |
| Net income | −CN¥257,594 | CN¥9.2m | −CN¥11.2m | CN¥8.2m | CN¥16.7m | CN¥8.3m | CN¥6.2m | CN¥9.6m |
| Diluted earnings per share | -0.00 | 0.12 | -0.15 | 0.11 | 0.22 | 0.11 | 0.08 | 0.13 |
| Cash from operations | — | — | — | CN¥6.0m | CN¥20.0m | CN¥13.0m | CN¥9.0m | CN¥14.0m |
| Capital spending | −CN¥1.0m | −CN¥26.0m | −CN¥19.0m | −CN¥17.0m | −CN¥4.0m | −CN¥24.0m | −CN¥15.0m | −CN¥54.0m |
| Free cash flow | — | — | — | −CN¥11.0m | CN¥16.0m | −CN¥11.0m | −CN¥6.0m | −CN¥40.0m |
| Total assets | CN¥1.07bn | CN¥1.05bn | CN¥1.06bn | CN¥1.05bn | CN¥1.06bn | CN¥1.04bn | CN¥1.06bn | CN¥976.9m |
| Cash and short-term investments | — | — | — | CN¥243.8m | CN¥260.2m | CN¥263.7m | CN¥275.6m | CN¥359.4m |
| Debt | CN¥27.8m | CN¥27.9m | — | CN¥102,930 | CN¥10.0m | CN¥10.0m | CN¥10.0m | CN¥227,426 |
| Shareholders' equity | CN¥871.4m | CN¥882.3m | CN¥904.3m | CN¥916.7m | CN¥910.8m | CN¥913.8m | CN¥905.7m | CN¥898.5m |
Financial ratios
Data as of 28 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2012 | FY2011 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 76.3% | 76.1% | 79.8% | 81.4% | 83.6% | 84.5% | — | — |
| Operating margin | 9.1% | 18.2% | 25.9% | 19.8% | 20.7% | 20.6% | — | — |
| Net margin | 9.3% | 15.7% | 22.4% | 15.9% | 18.2% | 17.4% | — | — |
| Return on equity | 2.4% | 4.4% | 5.1% | 4.3% | 9.9% | 10.5% | — | — |
| Return on assets | 2.1% | 3.8% | 4.7% | 4.0% | 8.7% | 9.0% | — | — |
| Free cash flow yield | 6.0% | 9.9% | 8.8% | 6.0% | 5.3% | 5.2% | — | — |
| Revenue growth | -8.4% | 13.7% | -11.7% | -10.6% | -0.2% | -11.9% | — | — |
| Earnings growth | -45.6% | -20.3% | 24.0% | -21.7% | 4.6% | -8.9% | — | — |
| Current ratio | 3.88x | 4.71x | 11.80x | 18.18x | 9.08x | 6.75x | — | — |
| Debt to equity | — | 0.01x | — | 0.00x | 0.00x | — | 0.06x | 0.07x |
| Equity ratio | 85.2% | 85.2% | 92.1% | 92.9% | 88.1% | 85.7% | — | — |
| Interest coverage | 48.20x | 432.89x | 751.95x | 1719.78x | 1657.68x | 1628.81x | — | — |
| R&D as a share of sales | 4.8% | 4.0% | 3.9% | 4.6% | 4.7% | 1.5% | — | — |
| Buybacks as a share of market value | -0.0% | 5.3% | 0.0% | -33.4% | 0.0% | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -2.8% | -3.9% | 2.0% |
| Operating income | -26.1% | -18.7% | -6.4% |
| Net income | -18.7% | -15.1% | -5.9% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 76.2% | 78.4% | 80.5% | 82.0% |
| Operating margin | 13.7% | 18.0% | 19.0% | 19.8% |
| Net margin | 12.7% | 15.8% | 16.5% | 17.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 99.7 | 49.9 | 44.6 | 57.3 |
| Price to sales | 9.3 | 7.8 | 10.0 | 9.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 4 years. Last went ex-dividend on 1 Jun 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Paid in the year | 0.145 | 0.26 | 0.26 | 0.16 | 0.13 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.